PPT-Ten-year follow-up analysis of the PowerPoint Presentation

BCIRG 001 trial confirms superior DFS and OS benefit of adjuvant TAC docetaxel doxorubicin cyclophosphamide over FAC fluorouracil doxorubicin cyclophosphamide

Upload by celsa-spraggs
Published on 2015-10-13

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/159335" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Ten-year follow-up analysis of the" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.